Abstract
Tobacco consumption is one of the leading causes of preventable death. While some public policies have been effective in reducing the smoking prevalence in the United States, high tobacco excise taxes do not appear to deter all individuals from starting smoking nor to affect the smoking intensity of all those who do smoke. Here, we analyse whether someone’s genetic predisposition to smoking may explain why individuals smoke despite high tobacco excise taxes. For this purpose, we interact polygenic risk scores for smoking behaviour with state-level excise tax rates on tobacco. Our analyses exploiting longitudinal data (1992-2016) from the US Health and Retirement Study show that someone’s genetic propensity to smoking moderates the effect of tobacco excise taxes on smoking behaviour along the extensive margin (smoking vs. not smoking) and the intensive margin (the amount of tobacco consumed). That is, when tobacco excise taxes are relatively low, those with a high genetic predisposition to smoking are more likely (i) to smoke, and (ii) to smoke a relatively high number of cigarettes per day. In our sample, we do not find a significant interaction effect on smoking cessation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank the National Institute on Aging (U01 AG009740), the Health and Retirement Study (HRS application number HRS RDA 2019-025) staff, and the HRS participants. C.A.R. acknowledges funding from the New Opportunities for Research Funding Agency Cooperation in Europe (NORFACE-DIAL grant 462-16-100).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Erasmus Research Institute of Management (IRB NE 2019-15)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email address: nrietveld{at}ese.eur.nl (Cornelius A. Rietveld)
Data Availability
HRS data are available (after registration) via https://hrsdata.isr.umich.edu/
